Letter comments on: "Twelve years of European cancer drug approval-a systematic investigation of the 'magnitude of clinical benefit'"
- PMID: 35525185
- PMCID: PMC9092263
- DOI: 10.1016/j.esmoop.2022.100487
Letter comments on: "Twelve years of European cancer drug approval-a systematic investigation of the 'magnitude of clinical benefit'"
Conflict of interest statement
Disclosure The authors have declared no conflicts of interest.
Comment on
-
Twelve years of European cancer drug approval-a systematic investigation of the 'magnitude of clinical benefit'.ESMO Open. 2021 Jun;6(3):100166. doi: 10.1016/j.esmoop.2021.100166. Epub 2021 Jun 1. ESMO Open. 2021. PMID: 34087744 Free PMC article.
References
-
- ESMO-Magnitude of Clinical Benefit Scale Scorecards. https://www.esmo.org/guidelines/esmo-mcbs/esmo-mcbs-scorecards Available at.
-
- World Health Organization . World Health Organization; Geneva, Switzerland: 2021. World Health Organization Model List of Essential Medicines – 22nd List. 2021 (WHO/MHP/HPS/EML/2021.02)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
